Medication info
Rosuvastatin Calcium Tablets 10mg

Rosuvastatin Calcium Tablets 10mg

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Intro Bio Pharma Co., Ltd.
Appearance
Pink, round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201603595 · Approved 2016.06.20 · Insurance code 052400150

Summary

Main use
Improves dyslipidemia, inhibits the progression of atherosclerosis, and prevents cardiovascular disease
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and should continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The starting dose is 5 milligrams once daily. The dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is required. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased up to a maximum of 20 milligrams daily. 3. Elderly patients: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended starting dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Children's dosage
2. Pediatric patients with heterozygous familial hypercholesterolemia (age 10 to 17 years): The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Children younger than 10 years: Safety and efficacy have not been established.

Ingredients

Manufacturer
Intro Bio Pharma Co., Ltd.

Efficacy & effects

Improves dyslipidemia, inhibits the progression of atherosclerosis, and prevents cardiovascular disease

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • combined hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • personal history of early coronary artery disease
View approved original text

This medication is mainly used as an adjunct for patients with hypercholesterolemia and hyperlipidemia when diet and exercise alone are not sufficient. It is especially effective in patients with familial hypercholesterolemia or primary dysbetalipoproteinemia. It lowers the total cholesterol and LDL cholesterol levels, slowing the progression of atherosclerosis, and can be used in pediatric patients aged 10 years and older under specific criteria. Furthermore, in adult patients at high risk for cardiovascular disease, it also reduces the risks of stroke, myocardial infarction, and arterial revascularization. Therefore, this drug is used to improve hyperlipidemia and cardiovascular disease risk.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and should continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The starting dose is 5 milligrams once daily. The dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is required. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased up to a maximum of 20 milligrams daily. 3. Elderly patients: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended starting dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Children's dosage

2. Pediatric patients with heterozygous familial hypercholesterolemia (age 10 to 17 years): The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Children younger than 10 years: Safety and efficacy have not been established.

Precautions

This drug should not be administered to certain patients. For example, patients who are allergic to any component of this medication, those with severely impaired liver function, patients with muscular diseases, and pregnant or breastfeeding women should not use this medication. Since this drug may affect liver function, patients with a history of liver disease or those who consume alcohol heavily should undergo multiple liver function tests before using it. Additionally, patients with conditions such as hypothyroidism or nephrotic syndrome should first treat the underlying disease. Since muscle-related side effects such as muscle pain or weakness may occur, immediate notification to healthcare professionals is required if these symptoms appear, and the medication may need to be discontinued if necessary. Special caution is advised for patients with impaired kidney function, elderly patients, and those with alcohol abuse, as they are at higher risk for muscle side effects. This medication contains lactose, so genetically predisposed patients with lactose intolerance should not use it. It is recommended to regularly undergo liver function tests and muscle enzyme tests while taking this medication. If severe liver damage or severe skin reactions occur, the medication should be discontinued immediately. This drug may interact with other medications, so especially when taken with specific antiviral agents, immunosuppressants, and fibrate drugs, consultation with healthcare professionals is necessary. Co-administration with certain drugs may increase the blood concentration of this medication, raising the risk of side effects. Women who are pregnant or planning to become pregnant should not take this medication and should be on effective contraception. It is also advisable for breastfeeding women to avoid using this drug. In the case of overdose, as there is no specific antidote, symptomatic treatment and liver function and muscle enzyme tests are necessary. This medication can cause dizziness, so caution is advised when driving or operating machinery. In summary, this medication may impact the liver and muscles, thus requiring regular examinations and careful monitoring before and after usage. Immediate consultation with healthcare professionals is required if any abnormal symptoms occur.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, myalgia, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink, round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.